Zota Health Care (ZOTA) Fundamentals 2026 — Revenue Analysis | SniperIQ
Zota Health Care (ZOTA) is a India-listed Healthcare company in Biotechnology with a market capitalization of ₹3,875 Crore, trading at ₹1277.40 on the NSE. This SniperIQ fundamentals page covers Zota Health Care's valuation, profitability (net margin -13.7%), revenue (₹539 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Zota Health Care's market cap?
Zota Health Care (ZOTA) has a market capitalization of approximately ₹3,875 Crore, trading at ₹1277.40 on the NSE. Market cap moves with the live share price.
What is Zota Health Care's P/E ratio?
Zota Health Care's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 6.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Zota Health Care?
Zota Health Care runs a net profit margin of -13.7%, a gross margin of 20.7%, and an operating margin of -11.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Zota Health Care generate?
Zota Health Care reported revenue of ₹539 Crore for fiscal year 2026, with net income of -₹74 Crore and earnings per share (EPS) of -22.46. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Zota Health Care pay a dividend?
Zota Health Care offers a trailing dividend yield of about 0.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Zota Health Care financially healthy?
Zota Health Care carries a debt-to-equity ratio of 0.39x and a current ratio of 1.93x, with a market beta of 0.34. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Zota Health Care a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Zota Health Care (ZOTA) the key facts are: market cap ₹3,875 Crore, revenue ₹539 Crore, 52-week range 1026.2-1740. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Zota Health Care's full fundamentals live
Get Zota Health Care's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.